The DOI matches its Crossref record; 152 of the 152 references it cites were found in a registry or an index.
Interactions between inflammation and lipid metabolism: Relevance for efficacy of anti-inflammatory drugs in the treatment of atherosclerosis
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Inflammation in atherosclerosis
Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315
Metabolic Endotoxemia Initiates Obesity and Insulin Resistance
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026
Inflammation in Atherosclerosis
Libby, P. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.179705 · Cited by 3,736
TLR4 links innate immunity and fatty acid-induced insulin resistance
Shi, H., Kokoeva, M. V., Inouye, K., Tzameli, I., Yin, H., & Flier, J. S. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28898 · Cited by 3,690
Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L., & Spiegelman, B. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117936 · Cited by 3,543
Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43
Maslowski, K. M., Vieira, A. T., Ng, A., Kranich, J., Sierro, F., Yu, D., Schilter, H. C., Rolph, M. S., Mackay, F., Artis, D., et al. (2009) · Nature · doi:10.1038/nature08530 · Cited by 3,241
Elevated C-reactive protein levels in overweight and obese adults
Visser, M. (1999) · JAMA · doi:10.1001/jama.282.22.2131 · Cited by 2,494
Ridker, P. M., Rifai, N., Stampfer, M. J., & Hennekens, C. H. (2000) · Circulation · doi:10.1161/01.cir.101.15.1767 · Cited by 2,429
Oh, D. Y., Talukdar, S., Bae, E. J., Imamura, T., Morinaga, H., Fan, W., Li, P., Lu, W. J., Watkins, S. M., & Olefsky, J. M. (2010) · Cell · doi:10.1016/j.cell.2010.07.041 · Cited by 2,428
The immune system in atherosclerosis
Hansson, G. K., & Hermansson, A. (2011) · Nature Immunology · doi:10.1038/ni.2001 · Cited by 2,317
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
Cai, D., Yuan, M., Frantz, D. F., Melendez, P. A., Hansen, L., Lee, J., & Shoelson, S. E. (2005) · Nature Medicine · doi:10.1038/nm1166 · Cited by 2,245
Macrophage-specific PPARγ controls alternative activation and improves insulin resistance
Odegaard, J. I., Ricardo-Gonzalez, R. R., Goforth, M. H., Morel, C. R., Subramanian, V., Mukundan, L., Eagle, A. R., Vats, D., Brombacher, F., Ferrante, A. W., et al. (2007) · Nature · doi:10.1038/nature05894 · Cited by 2,107
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
Tedgui, A., & Mallat, Z. (2006) · Physiological Reviews · doi:10.1152/physrev.00024.2005 · Cited by 1,701
The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β
Yin, M.-J., Yamamoto, Y., & Gaynor, R. B. (1998) · Nature · doi:10.1038/23948 · Cited by 1,590
Khovidhunkit, W., Kim, M.-S., Memon, R. A., Shigenaga, J. K., Moser, A. H., Feingold, K. R., & Grunfeld, C. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r300019-jlr200 · Cited by 1,481
Reciprocal regulation of inflammation and lipid metabolism by liver X receptors
Joseph, S. B., Castrillo, A., Laffitte, B. A., Mangelsdorf, D. J., & Tontonoz, P. (2003) · Nature Medicine · doi:10.1038/nm820 · Cited by 1,158
(2012) · The Lancet · doi:10.1016/s0140-6736(12)60110-x · Cited by 1,146
PPAR-γ is a major driver of the accumulation and phenotype of adipose tissue Treg cells
Cipolletta, D., Feuerer, M., Li, A., Kamei, N., Lee, J., Shoelson, S. E., Benoist, C., & Mathis, D. (2012) · Nature · doi:10.1038/nature11132 · Cited by 1,143
Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators
Staels, B., Koenig, W., Habib, A., Merval, R., Lebret, M., Torra, I. P., Delerive, P., Fadel, A., Chinetti, G., Fruchart, J.-C., et al. (1998) · Nature · doi:10.1038/31701 · Cited by 1,134
Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study
Choi, H. K., Hernán, M. A., Seeger, J. D., Robins, J. M., & Wolfe, F. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08213-2 · Cited by 1,127
Delerive, P., De Bosscher, K., Besnard, S., Vanden Berghe, W., Peters, J. M., Gonzalez, F. J., Fruchart, J.-C., Tedgui, A., Haegeman, G., & Staels, B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32048 · Cited by 1,089
Rajamäki, K., Lappalainen, J., Öörni, K., Välimäki, E., Matikainen, S., Kovanen, P. T., & Eklund, K. K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011765 · Cited by 1,039
Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXRα
Venkateswaran, A., Laffitte, B. A., Joseph, S. B., Mak, P. A., Wilpitz, D. C., Edwards, P. A., & Tontonoz, P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.200367697 · Cited by 1,005
Synthetic LXR ligand inhibits the development of atherosclerosis in mice
Joseph, S. B., McKilligin, E., Pei, L., Watson, M. A., Collins, A. R., Laffitte, B. A., Chen, M., Noh, G., Goodman, J., Hagger, G. N., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.112059299 · Cited by 947
Gadaleta, R. M., van Erpecum, K. J., Oldenburg, B., Willemsen, E. C. L., Renooij, W., Murzilli, S., Klomp, L. W. J., Siersema, P. D., Schipper, M. E. I., Danese, S., et al. (2011) · Gut · doi:10.1136/gut.2010.212159 · Cited by 870
(2012) · The Lancet · doi:10.1016/s0140-6736(11)61931-4 · Cited by 823
Ridker, P. M., Thuren, T., Zalewski, A., & Libby, P. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.06.012 · Cited by 799
Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion.
Brand, K., Page, S., Rogler, G., Bartsch, A., Brandl, R., Knuechel, R., Page, M., Kaltschmidt, C., Baeuerle, P. A., & Neumeier, D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118598 · Cited by 798
Maini, R. N., Taylor, P. C., Szechinski, J., Pavelka, K., Bröll, J., Balint, G., Emery, P., Raemen, F., Petersen, J., Smolen, J., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22033 · Cited by 790
Ross, R., & Harker, L. (1976) · Science · doi:10.1126/science.822515 · Cited by 762
LXR signaling couples sterol metabolism to proliferation in the acquired immune response
Bensinger, S. J., Bradley, M. N., Joseph, S. B., Zelcer, N., Janssen, E. M., Hausner, M. A., Shih, R., Parks, J. S., Edwards, P. A., Jamieson, B. D., et al. (2008) · Cell · doi:10.1016/j.cell.2008.04.052 · Cited by 711
Awtry, E. H., & Loscalzo, J. (2000) · Circulation · doi:10.1161/01.cir.101.10.1206 · Cited by 690
Atherogenesis in perspective: Hypercholesterolemia and inflammation as partners in crime
Steinberg, D. (2002) · Nature Medicine · doi:10.1038/nm1102-1211 · Cited by 679
The bile acid receptor FXR is a modulator of intestinal innate immunity
Vavassori, P., Mencarelli, A., Renga, B., Distrutti, E., & Fiorucci, S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803978 · Cited by 655
Cytokines and atherosclerosis: a comprehensive review of studies in mice
Kleemann, R., Zadelaar, S., & Kooistra, T. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn120 · Cited by 606
Marx, N., Sukhova, G. K., Collins, T., Libby, P., & Plutzky, J. (1999) · Circulation · doi:10.1161/01.cir.99.24.3125 · Cited by 599
Myasoedova, E., Crowson, C. S., Kremers, H. M., Roger, V. L., Fitz-Gibbon, P. D., Therneau, T. M., & Gabriel, S. E. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.135871 · Cited by 586
Targeting JNK for therapeutic benefit: from junk to gold?
Manning, A. M., & Davis, R. J. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1132 · Cited by 585
Transcriptional Repression of Atherogenic Inflammation: Modulation by PPARδ
Lee, C.-H., Chawla, A., Urbiztondo, N., Liao, D., Boisvert, W. A., & Evans, R. M. (2003) · Science · doi:10.1126/science.1087344 · Cited by 580
Nuclear Factor κB Signaling in Atherogenesis
de Winther, M. P. J., Kanters, E., Kraal, G., & Hofker, M. H. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000160340.72641.87 · Cited by 575
Ikonomidis, I., Andreotti, F., Economou, E., Stefanadis, C., Toutouzas, P., & Nihoyannopoulos, P. (1999) · Circulation · doi:10.1161/01.cir.100.8.793 · Cited by 573
Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids
Adkins, Y., & Kelley, D. S. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.12.004 · Cited by 557
Nilsson, N. E., Kotarsky, K., Owman, C., & Olde, B. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00488-1 · Cited by 540
Jacobsson, L., Turesson, C., Gülfe, A., Kapetanovic, M. C., Petersson, I. F., Saxne, T., & Geborek, P. (2005) · PubMed · Cited by 533
Control of Macrophage Activation and Function by PPARs
Chawla, A. (2010) · Circulation Research · doi:10.1161/circresaha.110.216523 · Cited by 531
Ridker, P. M., Howard, C. P., Walter, V., Everett, B., Libby, P., Hensen, J., & Thuren, T. (2012) · Circulation · doi:10.1161/circulationaha.112.122556 · Cited by 530
Lee, J. Y., Zhao, L., Youn, H. S., Weatherill, A. R., Tapping, R., Feng, L., Lee, W. H., Fitzgerald, K. A., & Hwang, D. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312990200 · Cited by 493
Wouters, K., van Gorp, P. J., Bieghs, V., Gijbels, M. J., Duimel, H., Lütjohann, D., Kerksiek, A., van Kruchten, R., Maeda, N., Staels, B., et al. (2008) · Hepatology · doi:10.1002/hep.22363 · Cited by 476
The Liver X Receptor (LXR) and Hepatic Lipogenesis
Cha, J.-Y., & Repa, J. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m605023200 · Cited by 470
Gervois, P., Fruchart, J.-C., Delerive, P., & Staels, B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004045200 · Cited by 456
McMahon, M., Grossman, J., FitzGerald, J., Dahlin‐Lee, E., Wallace, D. J., Thong, B. Y., Badsha, H., Kalunian, K., Charles, C., Navab, M., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21976 · Cited by 431
Medium-chain Fatty Acids as Ligands for Orphan G Protein-coupled Receptor GPR84
Wang, J., Wu, X., Simonavicius, N., Tian, H., & Ling, L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608019200 · Cited by 417
Tumor necrosis factor-alpha stimulates hepatic lipogenesis in the rat in vivo.
Feingold, K. R., & Grunfeld, C. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113046 · Cited by 403
The Effects of Salsalate on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Trial
Goldfine, A. B., Fonseca, V., Jablonski, K. A., Pyle, L., Staten, M. A., Shoelson, S. E., & for the TINSAL-T2D (Targeting Inflammation Using Salsalate in Type 2 Diabetes) Study Team* (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-6-201003160-00004 · Cited by 388
PRODANOWICH, S., MA, F., TAYLOR, J., PEZON, C., FASIHI, T., & KIRSNER, R. (2005) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2004.06.017 · Cited by 384
Lipoprotein metabolism in patients with severe sepsis
van Leeuwen, H. J., Heezius, E. C. J. M., Dallinga, G. M., van Strijp, J. A. G., Verhoef, J., & van Kessel, K. P. M. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000059724.08290.51 · Cited by 378
Role of Cytokines in Inducing Hyperlipidemia
Feingold, K. R., & Grunfeld, C. (1992) · Diabetes · doi:10.2337/diab.41.2.s97 · Cited by 378
Anti-inflammatory effects of aspirin and sodium salicylate
Amann, R., & Peskar, B. A. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01828-9 · Cited by 372
PPAR-δ senses and orchestrates clearance of apoptotic cells to promote tolerance
Mukundan, L., Odegaard, J. I., Morel, C. R., Heredia, J. E., Mwangi, J. W., Ricardo-Gonzalez, R. R., Goh, Y. P. S., Eagle, A. R., Dunn, S. E., Awakuni, J. U. H., et al. (2009) · Nature Medicine · doi:10.1038/nm.2048 · Cited by 368
Multi-targeted therapy of cancer by omega-3 fatty acids
Berquin, I. M., Edwards, I. J., & Chen, Y. Q. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.044 · Cited by 364
Feingold, K., Staprans, I., Memon, R., Moser, A., Shigenaga, J., Doerrler, W., Dinarello, C., & Grunfeld, C. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41334-3 · Cited by 346
Ikonomidis, I., Lekakis, J. P., Nikolaou, M., Paraskevaidis, I., Andreadou, I., Kaplanoglou, T., Katsimbri, P., Skarantavos, G., Soucacos, P. N., & Kremastinos, D. T. (2008) · Circulation · doi:10.1161/circulationaha.107.731877 · Cited by 307
Anti-inflammatory therapeutics for the treatment of atherosclerosis
Charo, I. F., & Taub, R. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3444 · Cited by 306
Changes in serum lipoprotein pattern induced by acute infections
Sammalkorpi, K., Valtonen, V., Kerttula, Y., Nikkilä, E., & Taskinen, M.-R. (1988) · Metabolism · doi:10.1016/0026-0495(88)90120-5 · Cited by 275
RIDKER, P. M. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03404.x · Cited by 270
Lukasova, M., Malaval, C., Gille, A., Kero, J., & Offermanns, S. (2011) · Journal of Clinical Investigation · doi:10.1172/jci41651 · Cited by 266
Coordination of inflammation and metabolism by PPAR and LXR nuclear receptors
Hong, C., & Tontonoz, P. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.07.016 · Cited by 253
Lipid profiles in untreated patients with rheumatoid arthritis.
Park, Y., Lee, S. K., Lee, W. K., Suh, C., Lee, C. W., Lee, C. H., Song, C. H., & Lee, J. (1999) · PubMed · Cited by 252
van Tits, L. J. H., Stienstra, R., van Lent, P. L., Netea, M. G., Joosten, L. A. B., & Stalenhoef, A. F. H. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.11.018 · Cited by 249
Georgiadis, A. N., Papavasiliou, E. C., Lourida, E. S., Alamanos, Y., Kostara, C., Tselepis, A. D., & Drosos, A. A. (2006) · Arthritis Research & Therapy · doi:10.1186/ar1952 · Cited by 247
Cyrus, T., Sung, S., Zhao, L., Funk, C. D., Tang, S., & Praticò, D. (2002) · Circulation · doi:10.1161/01.cir.0000027816.54430.96 · Cited by 247
Transsignaling of Interleukin-6 Crucially Contributes to Atherosclerosis in Mice
Schuett, H., Oestreich, R., Waetzig, G. H., Annema, W., Luchtefeld, M., Hillmer, A., Bavendiek, U., von Felden, J., Divchev, D., Kempf, T., et al. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.229435 · Cited by 243
Vascular COX-2 Modulates Blood Pressure and Thrombosis in Mice
Yu, Y., Ricciotti, E., Scalia, R., Tang, S. Y., Grant, G., Yu, Z., Landesberg, G., Crichton, I., Wu, W., Puré, E., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003787 · Cited by 236
Mechanisms for the anti-inflammatory effects of statins
Bu, D.-X., Griffin, G., & Lichtman, A. H. (2011) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283453e41 · Cited by 234
Johnston, A., Gudjonsson, J. E., Sigmundsdottir, H., Runar Ludviksson, B., & Valdimarsson, H. (2005) · Clinical Immunology · doi:10.1016/j.clim.2004.09.001 · Cited by 231
Kleemann, R., Verschuren, L., van Erk, M. J., Nikolsky, Y., Cnubben, N. H., Verheij, E. R., Smilde, A. K., Hendriks, H. F., Zadelaar, S., Smith, G. J., et al. (2007) · Genome Biology · doi:10.1186/gb-2007-8-9-r200 · Cited by 230
Interleukin-1 Receptor Antagonist Expression in Human Endothelial Cells and Atherosclerosis
Dewberry, R., Holden, H., Crossman, D., & Francis, S. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.11.2394 · Cited by 227
Higgs, G. A., Salmon, J. A., Henderson, B., & Vane, J. R. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.5.1417 · Cited by 222
Charles-Schoeman, C., Lee, Y. Y., Grijalva, V., Amjadi, S., FitzGerald, J., Ranganath, V. K., Taylor, M., McMahon, M., Paulus, H. E., & Reddy, S. T. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200493 · Cited by 222
The role of dysfunctional HDL in atherosclerosis
Navab, M., Reddy, S. T., Van Lenten, B. J., Anantharamaiah, G. M., & Fogelman, A. M. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800036-jlr200 · Cited by 221
Nofer, J.-R., Bot, M., Brodde, M., Taylor, P. J., Salm, P., Brinkmann, V., van Berkel, T., Assmann, G., & Biessen, E. A. L. (2007) · Circulation · doi:10.1161/circulationaha.106.641407 · Cited by 217
Elhage, R., Maret, A., Pieraggi, M.-T., Thiers, J. C., Arnal, J. F., & Bayard, F. (1998) · Circulation · doi:10.1161/01.cir.97.3.242 · Cited by 209
Infection and Inflammation Induce LDL Oxidation In Vivo
Memon, R. A., Staprans, I., Noor, M., Holleran, W. M., Uchida, Y., Moser, A. H., Feingold, K. R., & Grunfeld, C. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.6.1536 · Cited by 207
Leukocyte Activation by Triglyceride-Rich Lipoproteins
Alipour, A., van Oostrom, A. J. H. H. M., Izraeljan, A., Verseyden, C., Collins, J. M., Frayn, K. N., Plokker, T. W. M., Elte, J. W. F., & Castro Cabezas, M. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.159749 · Cited by 201
MERHISOUSSI, F., KWAK, B., MAGNE, D., CHADJICHRISTOS, C., BERTI, M., PELLI, G., JAMES, R., MACH, F., & GABAY, C. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.01.008 · Cited by 200
Antiatherosclerotic effect of farnesoid X receptor
Mencarelli, A., Renga, B., Distrutti, E., & Fiorucci, S. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01075.2008 · Cited by 199
Liver X Receptors in Atherosclerosis and Inflammation
Im, S.-S., & Osborne, T. F. (2011) · Circulation Research · doi:10.1161/circresaha.110.226878 · Cited by 192
Dynamic Changes in Regulatory T Cells Are Linked to Levels of Diet-Induced Hypercholesterolemia
Maganto-García, E., Tarrio, M. L., Grabie, N., Bu, D.-X., & Lichtman, A. H. (2011) · Circulation · doi:10.1161/circulationaha.110.006411 · Cited by 188
Hanniman, E. A., Lambert, G., McCarthy, T. C., & Sinal, C. J. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500390-jlr200 · Cited by 179
Schwartz, E. A., Zhang, W.-Y., Karnik, S. K., Borwege, S., Anand, V. R., Laine, P. S., Su, Y., & Reaven, P. D. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.201681 · Cited by 179
The Nuclear Receptor PPARs as Important Regulators of T-Cell Functions and Autoimmune Diseases
Choi, J.-M., & Bothwell, A. L. M. (2012) · Molecules and Cells · doi:10.1007/s10059-012-2297-y · Cited by 176
Park, Y.-B., Choi, H. K., Kim, M.-Y., Lee, W.-K., Song, J., Kim, D.-K., & Lee, S.-K. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01186-5 · Cited by 176
van Asseldonk, E. J. P., Stienstra, R., Koenen, T. B., Joosten, L. A. B., Netea, M. G., & Tack, C. J. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2992 · Cited by 173
FXR Deficiency Causes Reduced Atherosclerosis in Ldlr−/−Mice
Zhang, Y., Wang, X., Vales, C., Lee, F. Y., Lee, H., Lusis, A. J., & Edwards, P. A. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000235697.35431.05 · Cited by 169
Nishimoto, N., Ito, K., & Takagi, N. (2010) · Modern Rheumatology · doi:10.1007/s10165-010-0279-5 · Cited by 165
Svenungsson, E., Gunnarsson, I., Fei, G., Lundberg, I. E., Klareskog, L., & Frostegård, J. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11264 · Cited by 164
Isoda, K., Sawada, S., Ishigami, N., Matsuki, T., Miyazaki, K., Kusuhara, M., Iwakura, Y., & Ohsuzu, F. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000127025.48140.a3 · Cited by 164
Lewis, K. E., Kirk, E. A., McDonald, T. O., Wang, S., Wight, T. N., O’Brien, K. D., & Chait, A. (2004) · Circulation · doi:10.1161/01.cir.0000136819.93989.e1 · Cited by 163
Fatty acids and postprandial inflammation
Margioris, A. N. (2009) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e3283232a11 · Cited by 162
Hartman, H. B., Gardell, S. J., Petucci, C. J., Wang, S., Krueger, J. A., & Evans, M. J. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m800619-jlr200 · Cited by 162
Apolipoproteins modulate the inflammatory response to lipopolysaccharide
Berbée, J. F. P., Havekes, L. M., & Rensen, P. C. N. (2005) · Journal of Endotoxin Research · doi:10.1179/096805105x35215 · Cited by 160
Self-citationBieghs, V., Wouters, K., van Gorp, P. J., Gijbels, M. J. J., de Winther, M. P. J., Binder, C. J., Lütjohann, D., Febbraio, M., Moore, K. J., van Bilsen, M., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.02.051 · Cited by 160
Kratzer, A., Buchebner, M., Pfeifer, T., Becker, T. M., Uray, G., Miyazaki, M., Miyazaki‐Anzai, S., Ebner, B., Chandak, P. G., Kadam, R. S., et al. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800376-jlr200 · Cited by 154
Maekawa, T., Takahashi, N., Tabeta, K., Aoki, Y., Miyashita, H., Miyauchi, S., Miyazawa, H., Nakajima, T. E., & Yamazaki, K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020240 · Cited by 153
Therapeutic elevation of HDL-cholesterol to prevent atherosclerosis and coronary heart disease
Chapman, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.02.003 · Cited by 150
Hudgins, L. C., Parker, T. S., Levine, D. M., Gordon, B. R., Saal, S. D., Jiang, X., Seidman, C. E., Tremaroli, J. D., Lai, J., & Rubin, A. L. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200440-jlr200 · Cited by 142
Infliximab Restores Glucose Homeostasis in an Animal Model of Diet-Induced Obesity and Diabetes
ARAUJO, E. P. D., de Souza, C. T., Ueno, M., Cintra, D. E., Bértolo, M. B., Carvalheira, J. B. C., Saad, M. J. A., & Velloso, L. A. (2007) · Endocrinology · doi:10.1210/en.2007-0132 · Cited by 142
Westerterp, M., Berbée, J. F. P., Pires, N. M., van Mierlo, G. J. D., Kleemann, R., Romijn, J. A., Havekes, L. M., & Rensen, P. C. N. (2007) · Circulation · doi:10.1161/circulationaha.107.693382 · Cited by 142
Self-citationLibby, P., & Plutzky, J. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.11.004 · Cited by 138
Prospective new biological therapies for rheumatoid arthritis
Šenolt, L., Vencovský, J., Pavelká, K., et al. (2009) · Autoimmunity Reviews · doi:10.1016/j.autrev.2009.03.010 · Cited by 138
Effects of FXR in foam-cell formation and atherosclerosis development
Guo, G. L., Santamarina-Fojo, S., Akiyama, T. E., Amar, M. J., Paigen, B. J., Brewer, B., & Gonzalez, F. J. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2006.09.018 · Cited by 137
Greig, F. H., Kennedy, S., & Spickett, C. M. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.10.481 · Cited by 135
Yazdani‐Biuki, B., Stelzl, H., Brezinschek, H. P., Hermann, J., Mueller, T., Krippl, P., Graninger, W. B., & Wascher, T. C. (2004) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2004.01390.x · Cited by 133
Kawashiri, S., Kawakami, A., Yamasaki, S., Imazato, T., Iwamoto, N., Fujikawa, K., Aramaki, T., Tamai, M., Nakamura, H., Ida, H., et al. (2011) · Rheumatology International · doi:10.1007/s00296-009-1303-y · Cited by 129
PPARs: the vasculature, inflammation and hypertension
Duan, S. Z., Usher, M. G., & Mortensen, R. M. (2009) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e328325803b · Cited by 129
Anti-inflammatory and metabolic actions of FXR: Insights into molecular mechanisms
Hollman, D. A. A., Milona, A., van Erpecum, K. J., & van Mil, S. W. C. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2012.07.004 · Cited by 121
Leonarduzzi, G., Gamba, P., Gargiulo, S., Biasi, F., & Poli, G. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.09.031 · Cited by 121
Tannock, L. R., O’Brien, K. D., Knopp, R. H., Retzlaff, B. M., Fish, B. E., Wener, M. H., Kahn, S. E., & Chait, A. (2005) · Circulation · doi:10.1161/circulationaha.104.506188 · Cited by 118
Wascher, T. C., Lindeman, J. H. N., Sourij, H., Kooistra, T., Pacini, G., & Roden, M. (2010) · Molecular Medicine · doi:10.2119/molmed.2010.00221 · Cited by 114
Nishimoto, N., Ito, K., & Takagi, N. (2010) · Modern Rheumatology · doi:10.3109/s10165-010-0279-5 · Cited by 113
NASH and atherosclerosis are two aspects of a shared disease: Central role for macrophages
Bieghs, V., Rensen, P. C. N., Hofker, M. H., & Shiri‐Sverdlov, R. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.08.041 · Cited by 105
Self-citationHambruch, E., Miyazaki‐Anzai, S., Hahn, U. K., Matysik, S., Boettcher, A., Perović‐Ottstadt, S., Schlüter, T., Kinzel, O. D., Krol, H. D., Deuschle, U., et al. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.196519 · Cited by 103
Treatment With Methotrexate Inhibits Atherogenesis in Cholesterol-Fed Rabbits
Bulgarelli, A., Dias, A. A. M., Caramelli, B., & Maranhão, R. C. (2011) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318241c385 · Cited by 101
Oh, D. Y., & Lagakos, W. (2011) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e3283479230 · Cited by 100
New Roles of HDL in Inflammation and Hematopoiesis
Zhu, X., & Parks, J. S. (2012) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071811-150709 · Cited by 100
Mechanisms of Dyslipoproteinemias in Systemic Lupus Erythematosus
Borba, E. F., de Carvalho, J. F., & Bonfá, E. (2006) · Journal of Immunology Research · doi:10.1080/17402520600876945 · Cited by 89
Isoda, K., Sawada, S., Ayaori, M., Matsuki, T., Horai, R., Kagata, Y., Miyazaki, K., Kusuhara, M., Okazaki, M., Matsubara, O., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m412220200 · Cited by 88
Macrophage SR-BI regulates LPS-induced pro-inflammatory signaling in mice and isolated macrophages
Cai, L., Wang, Z., Meyer, J. M., Ji, A., & van der Westhuyzen, D. R. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m023234 · Cited by 83
Anti-inflammatory effects of apolipoprotein A-I in the rabbit
Patel, S., Bartolo, B. A. D., Nakhla, S., Heather, A. K., Mitchell, T. W., Jessup, W., Celermajer, D. S., Barter, P. J., & Rye, K.-A. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.05.035 · Cited by 82
Kooistra, T., Verschuren, L., der Weij, J. D. V.-V., Köenig, W., Toet, K. H., Princen, H. M. G., & Kleemann, R. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000238348.05028.14 · Cited by 80
Olofsson, P. S., Sheikine, Y., Jatta, K., Ghaderi, M., Samnegård, A., Eriksson, P. O., & Sirsjö, A. (2009) · Circulation Journal · doi:10.1253/circj.cj-08-1150 · Cited by 78
Protein Kinase C β/Early Growth Response-1 Pathway
Yan, S., Harja, E., Andrassy, M., Fujita, T., & Schmidt, A. M. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.05.063 · Cited by 75
Brody, M., Böhm, I., & Bauer, R. (1993) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.1993.31.10.667 · Cited by 73
FXR ligands protect against hepatocellular inflammation via SOCS3 induction
Xu, Z., Huang, G., Gong, W., Zhou, P., Zhao, Y., Zhang, Y., Zeng, Y., Gao, M., Pan, Z., & He, F. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.04.015 · Cited by 71
Marculescu, R., Endler, G., Schillinger, M., Iordanova, N., Exner, M., Hayden, E., Huber, K., Wagner, O. F., & Mannhalter, C. (2002) · Diabetes · doi:10.2337/diabetes.51.12.3582 · Cited by 70
Pollono, E. N., Lopez-Olivo, M. A., Martínez‐López, J., & Suarez-Almazor, M. E. (2010) · Clinical Rheumatology · doi:10.1007/s10067-010-1405-7 · Cited by 63
Snel, M., van Diepen, J. A., Stijnen, T., Pijl, H., Romijn, J. A., Meinders, A. E., Voshol, P. J., & Jazet, I. M. (2011) · Food and Chemical Toxicology · doi:10.1016/j.fct.2011.09.032 · Cited by 57
Interleukin-1 and lipid metabolism in the rat
Argilés, J. M. A., López-Soriano, F. J., Evans, R. D., & Williamson, D. H. (1989) · Biochemical Journal · doi:10.1042/bj2590673 · Cited by 56
Woo, J. M. P., Lin, Z., Navab, M., Dyck, C. V., Trejo-Lopez, Y., Woo, K. M. T., Li, H., Castellani, L. W., Wang, X., Iikuni, N., et al. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3020 · Cited by 54
Hepatocyte-specific IKKβ expression aggravates atherosclerosis development in APOE*3-Leiden mice
Wong, M. C., van Diepen, J. A., Hu, L., Guigas, B., de Boer, H. C., van Puijvelde, G. H., Kuiper, J., van Zonneveld, A. J., Shoelson, S. E., Voshol, P. J., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.06.055 · Cited by 43
Self-citationLiver X Receptors, Atherosclerosis and Inflammation
Michael, D. R., Ashlin, T. G., Buckley, M. L., & Ramji, D. P. (2012) · Current Atherosclerosis Reports · doi:10.1007/s11883-012-0239-y · Cited by 39
Faghihimani, E., Aminorroaya, A., Rezvanian, H., Adibi, P., Ismail‐Beigi, F., & Amini, M. (2012) · Endocrine Practice · doi:10.4158/ep12064.or · Cited by 36
Interleukin 1B Variant -1473G/C (rs1143623) Influences Triglyceride and Interleukin 6 Metabolism
Delgado‐Lista, J., García‐Ríos, A., Pérez‐Martínez, P., Solivera, J., Yubero‐Serrano, E. M., Fuentes, F. J., Parnell, L. D., Shen, J., Gómez, P., Jiménez, Y., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2455 · Cited by 34
Sphingosine‐1‐phosphate and FTY720 as anti‐atherosclerotic lipid compounds
Tölle, M., Levkau, B., Kleuser, B., & van der Giet, M. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01776.x · Cited by 33
van Diepen, J. A., Vroegrijk, I. O. C. M., Berbée, J. F. P., Shoelson, S. E., Romijn, J. A., Havekes, L. M., Rensen, P. C. N., & Voshol, P. J. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00185.2011 · Cited by 33
Self-citationHepatocyte-specific IKK-β activation enhances VLDL-triglyceride production in APOE*3-Leiden mice
van Diepen, J. A., Wong, M. C., Guigas, B., Bos, J. E., Stienstra, R., Hodson, L., Shoelson, S. E., Berbée, J. F. P., Rensen, P. C. N., Romijn, J. A., et al. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m010405 · Cited by 29
Self-citationCardiovascular risk factors in inflammatory arthritis
Mirjafari, H., Alhusain, A., & Bruce, I. N. (2011) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283488c50 · Cited by 25
HDL and adaptive immunity: A tale of lipid rafts
Norata, G. D., & Catapano, A. L. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.08.020 · Cited by 24
der Weij, J. D. V.-V., Toet, K. H., Zadelaar, S., Wielinga, P. Y., Kleemann, R., Rensen, P. C. N., & Kooistra, T. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.09.006 · Cited by 22
Self-citation
Cited by
Li, R.-Y., Qin, Q., Yang, H.-C., Wang, Y.-Y., Mi, Y.-X., Yin, Y.-S., Wang, M., Yu, C.-J., & Tang, Y. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00542-y · Cited by 204
Lipid (per) oxidation in mitochondria: an emerging target in the ageing process?
Ademowo, O. S., Dias, H. K. I., Burton, D. G. A., & Griffiths, H. R. (2017) · Biogerontology · doi:10.1007/s10522-017-9710-z · Cited by 184
TREM2 regulates microglial lipid droplet formation and represses post-ischemic brain injury
Wei, W., Zhang, L., Xin, W., Pan, Y., Tatenhorst, L., Hao, Z., Gerner, S. T., Huber, S., Juenemann, M., Butz, M., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115962 · Cited by 122
Postprandial lipemia as a cardiometabolic risk factor
Pirillo, A., Norata, G. D., & Catapano, A. L. (2014) · Current Medical Research and Opinion · doi:10.1185/03007995.2014.909394 · Cited by 108
Reactive oxygen species in the pathogenesis of sarcopenia
Xu, H., Brown, J. L., Bhaskaran, S., & Van Remmen, H. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.11.046 · Cited by 61
Metadata
- Authors
- van Diepen, J. A., Berbée, J. F. P., Havekes, L. M., & Rensen, P. C. N.
- Venue
- Atherosclerosis
- Publisher
- Elsevier BV
- Published
- 2013-06
- Volume
- 228
- Issue
- 2
- Pages
- 306-315
- ISSN
- 0021-9150 (ISSN-L)
- OpenAlex
- W2136521846
- Cited by
- 292
- References
- 152
- FWCI
- 11.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.